Efficacy of Prednisolone Mouthwash in Management of Grade III Oral Submucous Fibrosis: A Newer Drug Regimen

[1] Pindborg JJ(1966)Oral submucous fibrosis Oral Surg Oral Med Oral Pathol 22 764-779

[2] Sirsat SM(1994)Oral submucous fibrosis: etiology, pathogenesis, and future research Bull World Health Organ 72 985-57

[3] Rajendran R(2011)A systematic review of medical interventions for oral submucous fibrosis and future research opportunities Oral Dis 17 42-439

[4] Kerr AR(1995)Oral submucous fibrosis: a new concept in surgical management: report of 100 cases Int J Oral Maxillofac Surg 24 433-1515

[5] Warnakulasuriya S(2017)Oral submucous fibrosis: newer proposed classification with critical updates in pathogenesis and management strategies Natl J Maxillofac Surg 8 89-329

[6] Mighell AJ(2009)Drug treatment of oral submucous fibrosis: a review of the literature J Oral Maxillofac Surg 67 1510-308

[7] Dietrich T(2003)Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up J Oral Pathol Med 32 323-1717

[8] Nasser M(2005)Vesiculo-erosive oral mucosal disease—management with topical corticosteroids: (2) protocols, monitoring of effects and adverse reactions, and the future J Dent Res 84 302-191

[9] Rimal J(2015)Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial Int J Cancer 136 1708-568

[10] Jalil A(2016)Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis Oral Surg Oral Med Oral Pathol Oral Radiol 122 178-328

[1] Pindborg JJ(1966)Oral submucous fibrosis Oral Surg Oral Med Oral Pathol 22 764-779

[2] Sirsat SM(1994)Oral submucous fibrosis: etiology, pathogenesis, and future research Bull World Health Organ 72 985-57

[3] Rajendran R(2011)A systematic review of medical interventions for oral submucous fibrosis and future research opportunities Oral Dis 17 42-439

[4] Kerr AR(1995)Oral submucous fibrosis: a new concept in surgical management: report of 100 cases Int J Oral Maxillofac Surg 24 433-1515

[5] Warnakulasuriya S(2017)Oral submucous fibrosis: newer proposed classification with critical updates in pathogenesis and management strategies Natl J Maxillofac Surg 8 89-329

[6] Mighell AJ(2009)Drug treatment of oral submucous fibrosis: a review of the literature J Oral Maxillofac Surg 67 1510-308

[7] Dietrich T(2003)Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up J Oral Pathol Med 32 323-1717

[8] Nasser M(2005)Vesiculo-erosive oral mucosal disease—management with topical corticosteroids: (2) protocols, monitoring of effects and adverse reactions, and the future J Dent Res 84 302-191

[9] Rimal J(2015)Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial Int J Cancer 136 1708-568

[10] Jalil A(2016)Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis Oral Surg Oral Med Oral Pathol Oral Radiol 122 178-328